http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101888241-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708 |
filingDate | 2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101888241-B1 |
titleOfInvention | A pharmaceutical composition for preventing or treating liver fibrosis comprising 8-hydroxydeoxyguanosine(OHdG) |
abstract | The present invention relates to a pharmaceutical composition for preventing or treating liver fibrosis or cirrhosis, comprising 8-OHdG or a pharmaceutically acceptable salt thereof, a method for preventing or treating liver fibrosis or cirrhosis using the above pharmaceutical composition, and a method for preventing or treating 8-OHdG or its The present invention relates to a food composition for improving liver fibrosis or cirrhosis, which comprises a pharmaceutically acceptable salt. The use of the pharmaceutical composition for the prevention or treatment of liver fibrosis or cirrhosis of the present invention can reduce the level of various markers whose expression level is increased by inducing hepatic fibrosis and thus can be used for effective prevention of liver cirrhosis caused by liver fibrosis or liver fibrosis Or treatments. |
priorityDate | 2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 249.